296 related articles for article (PubMed ID: 16649976)
1. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976
[TBL] [Abstract][Full Text] [Related]
2. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
3. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
[TBL] [Abstract][Full Text] [Related]
4. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
Karavitaki N; Brufani C; Warner JT; Adams CB; Richards P; Ansorge O; Shine B; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2005 Apr; 62(4):397-409. PubMed ID: 15807869
[TBL] [Abstract][Full Text] [Related]
5. Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors.
Jostel A; Mukherjee A; Hulse PA; Shalet SM
Clin Endocrinol (Oxf); 2005 Jun; 62(6):698-705. PubMed ID: 15943832
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).
Darendeliler F; Karagiannis G; Wilton P; Ranke MB; Albertsson-Wikland K; Anthony Price D; On Behalf Of The Kigs International Board
Acta Paediatr; 2006 Oct; 95(10):1284-90. PubMed ID: 16982503
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
Pereira AM; Schmid EM; Schutte PJ; Voormolen JH; Biermasz NR; van Thiel SW; Corssmit EP; Smit JW; Roelfsema F; Romijn JA
Clin Endocrinol (Oxf); 2005 Feb; 62(2):197-204. PubMed ID: 15670196
[TBL] [Abstract][Full Text] [Related]
9. Microsurgical treatment of craniopharyngiomas: report of 284 patients.
Shi XE; Wu B; Zhou ZQ; Fan T; Zhang YL
Chin Med J (Engl); 2006 Oct; 119(19):1653-63. PubMed ID: 17042979
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
Spoudeas HA; Charmandari E; Brook CG
Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
[TBL] [Abstract][Full Text] [Related]
11. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
12. Hypopituitarism oddities: craniopharyngiomas.
Karavitaki N
Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
[TBL] [Abstract][Full Text] [Related]
13. [Clinical feature and surgical treatment of recurrent craniopharyngiomas].
Qi ST; Pan J; Zhang JL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1078-81. PubMed ID: 14559699
[TBL] [Abstract][Full Text] [Related]
14. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
Müller HL; Gebhardt U; Pohl F; Flentje M; Emser A; Warmuth-Metz M; Kolb R; Calaminus G; Sörensen N
Klin Padiatr; 2006; 218(6):315-20. PubMed ID: 17080333
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.
Bakker B; Oostdijk W; Geskus RB; Stokvis-Brantsma WH; Vossen JM; Wit JM
Clin Endocrinol (Oxf); 2007 Oct; 67(4):589-97. PubMed ID: 17590170
[TBL] [Abstract][Full Text] [Related]
16. Craniopharyngioma: surgical experience of 309 cases in China.
Shi XE; Wu B; Fan T; Zhou ZQ; Zhang YL
Clin Neurol Neurosurg; 2008 Feb; 110(2):151-9. PubMed ID: 18063470
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.
Lin LL; El Naqa I; Leonard JR; Park TS; Hollander AS; Michalski JM; Mansur DB
J Neurosurg Pediatr; 2008 Feb; 1(2):126-30. PubMed ID: 18352781
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
Med Pediatr Oncol; 2003 Apr; 40(4):214-8. PubMed ID: 12555247
[TBL] [Abstract][Full Text] [Related]
19. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
20. Successful surgical treatment of craniopharyngioma in very young children.
Elliott RE; Wisoff JH
J Neurosurg Pediatr; 2009 May; 3(5):397-406. PubMed ID: 19409019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
